European Journal of Clinical Pharmacology

, Volume 10, Issue 2, pp 97–100 | Cite as

Serum digoxin levels in patients of a general practice in Germany

  • U. Gundert-Remy
  • C. Remy
  • E. Weber
Originals

Summary

Serum digoxin levels were determined in 33 outpatients of a general practice in the countryside, on three occasions at intervals of 8 weeks. All the patients were on long term digoxin treatment, about 2 years on average. About 14 days after the first and the second visits the results of the measurements were sent to the patients, with a comment about their reliability in taking treatment according to the serum digoxin level. At the first visit half of the serum digoxin level were lower than 0.5 ng/ml; the mean serum concentration was 0.52 ng/ml. There was no correlation between serum concentration and age, dose or creatinine level; but there was with replies to the question about regularity of drug intake. The mean serum level at the second and the third visits was 0.88 ng/ml and 0.89 ng/ml, respectively. A correlation was found between the dose and the serum digoxin level. From these results it seems that compliance by the patient plays a major role in producing steady state levels of drugs.

Key words

Serum digoxin outpatients general practice patients patient compliance 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Blackwell, B.: Drug defaulting. Clin. Pharmacol. exp. Ther.13, 841–848 (1972)Google Scholar
  2. 2.
    Butler, V.P.: Assay of digitalis in blood. Progr. cardiovasc. Dis.14, 571–584 (1972)Google Scholar
  3. 3.
    Carruthers, S.G., Kelly, J.G., McDevitt, D.G.: Plasma digoxin concentrations in patients on admission to hospital. Brit. Heart J.36, 707–712 (1974)Google Scholar
  4. 4.
    Gundert-Remy, U., Karacsonyi, P., Remy, C., Weber, E.: Beziehungen zwischen klinischem Bild und Digoxinspiegel bei Patienten einer Allgemeinpraxis. Verh. dtsch. Ges. Inn. Med.80, 1530–1533 (1974)Google Scholar
  5. 5.
    Ochs, H., Bodem, G., Dengler, H.J.: Die biologische Verfügbarkeit von Digoxin aus Kombinationspräparaten. Klin. Wschr.52, 637–639 (1974)Google Scholar
  6. 6.
    Porter, A.M.W.: Drug defaulting in a general practice. Brit. med. J.1969 I, 218–222Google Scholar
  7. 7.
    Smith, T.W., Butler, V.P., Haber, E.: Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay. New Engl. J. Med.281, 1212–1216 (1969)Google Scholar
  8. 8.
    Weintraub, M., Au, W.Y., Lasagna, L.: Compliance as a determinant of serum digoxin concentration. J. Amer. med. Ass.224, 481–485 (1973)Google Scholar

Copyright information

© Springer-Verlag 1976

Authors and Affiliations

  • U. Gundert-Remy
    • 1
  • C. Remy
    • 1
  • E. Weber
    • 1
  1. 1.Abteilung für Klinische Pharmakologie der Medizinischen UniversitätsklinikHeidelbergFederal Republic of Germany

Personalised recommendations